Ednah Ooko | Biochemistry | Innovative Research Award

Innovative Research Award

Ednah Ooko
Affiliation National Institute of Health, National Cancer Institute
Country United States
Scopus ID 57443950800
Documents 9
Citations 13,869
h-index 8
Subject Area Biochemistry
Event International Invention Awards
ORCID 0000-0001-8275-927X

Ednah Ooko

National Institute of Health, National Cancer Institute

Ednah Ooko is a researcher affiliated with the National Institute of Health, National Cancer Institute in the United States. Her scholarly profile reflects contributions within the field of biochemistry, emphasizing investigations that support biomedical discovery and translational cancer research. Through peer-reviewed publications and collaborations, her work contributes to understanding molecular mechanisms relevant to disease progression and therapeutic innovation. The research metrics associated with her academic profile demonstrate measurable scientific visibility, supporting consideration for recognition through the Innovative Research Award presented at the International Invention Awards.[1]

Abstract

Ednah Ooko has established an academic profile focused on biochemistry and cancer-related biomedical research through contributions associated with the National Institute of Health, National Cancer Institute. Her scholarly work demonstrates engagement with molecular investigations supporting improved understanding of disease biology, therapeutic development, and translational medicine. Citation metrics indicate broad recognition of research relevance, while collaborative publications reflect participation in multidisciplinary scientific initiatives. Collectively, these achievements illustrate sustained commitment to advancing biomedical knowledge and enhancing scientific evidence that benefits future clinical investigation, innovation, education, and international collaboration within the global research community through responsible scientific discovery efforts.[1]

Keywords

Biochemistry, Cancer Research, Molecular Biology, Translational Medicine, Biomedical Science, National Cancer Institute, Scientific Innovation, Research Excellence.

Introduction

Modern biomedical science depends upon interdisciplinary investigations capable of translating molecular discoveries into practical healthcare improvements. Researchers working within leading scientific institutions contribute by generating reproducible evidence, advancing laboratory methodologies, and supporting collaborative innovation. Within this environment, Ednah Ooko’s academic activities represent ongoing engagement with biochemical research addressing significant biological questions while contributing to the broader objectives of cancer science and biomedical advancement.[2]

Research Profile

The available scholarly profile identifies Ednah Ooko as a researcher associated with the National Institute of Health, National Cancer Institute, maintaining publication activity within biochemistry. Her indexed research output, citation performance, and international visibility indicate continued participation in scientific collaborations that strengthen biomedical understanding while supporting evidence-based investigation relevant to cancer biology and related molecular disciplines.[1]

Research Contributions

Research contributions attributed to Ednah Ooko demonstrate involvement in studies examining biochemical mechanisms and molecular pathways associated with human disease. Collaborative scientific publications contribute to expanding biomedical knowledge through experimentally supported findings, encouraging future investigations and strengthening the foundation for translational applications that may improve diagnostic approaches, therapeutic strategies, and scientific understanding across multiple biomedical research communities.[3]

Publications

The documented publication record includes peer-reviewed scientific articles indexed within internationally recognized databases. Although the overall publication count remains selective, the accumulated citation performance demonstrates meaningful academic influence. These publications contribute to scientific dialogue by supporting reproducibility, interdisciplinary collaboration, and continued exploration of biochemical processes relevant to cancer research and biomedical innovation.[1]

Research Impact

Research impact extends beyond publication volume through citation influence, collaborative engagement, and scientific relevance. The citation record associated with Ednah Ooko indicates that published findings have informed subsequent investigations, reflecting recognition by the research community. Such influence supports ongoing knowledge development while contributing to biomedical progress through evidence-based scientific communication and responsible dissemination of research outcomes.[4]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating measurable scientific contributions, academic integrity, and influence within their disciplines. Based on available bibliometric indicators, institutional affiliation, scholarly visibility, and contributions to biochemistry and biomedical research, Ednah Ooko presents characteristics consistent with evaluation criteria emphasizing scientific excellence, innovation, collaboration, and continued advancement of internationally relevant research initiatives.[5]

Conclusion

Ednah Ooko’s scholarly profile reflects sustained participation in biomedical and biochemical research supported by recognized institutional affiliation and measurable citation performance. Her research activities contribute to scientific understanding within cancer-related investigations while encouraging collaborative advancement across biomedical disciplines. Collectively, these characteristics provide an appropriate foundation for academic recognition through the Innovative Research Award at the International Invention Awards.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Ednah Ooko, Author ID 57443950800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57443950800
  2. ORCID. (n.d.). Ednah Ooko Research Profile.
    https://orcid.org/0000-0001-8275-927X
  3. Biomolecules.(2025.) Predictive and Prognostic Relevance of ABC Transporters for Resistance to Anthracycline Derivatives.
    https://doi.org/10.3390/biom15070971
  4. Biology (2024.) Identification of Cuproptosis-Associated Prognostic Gene Expression Signatures from 20 Tumor Types.
    https://doi.org/10.3390/biology13100793
  5. International Invention Awards.(2026.) Award Information.
    https://inventionawards.org/

Anna Klimovich | Biochemistry | Young Scientist Award

Dr. Anna Klimovich | Biochemistry | Young Scientist Award 

Dr. Anna Klimovich | G.B. Elyakov Pacific Institute of Bioorganic Chemistry Far-Eastern Branch of the Russian Academy of Sciences | Russia

Dr. Anna Klimovich is a PhD candidate in biochemistry with a decade of experience as a research fellow, specializing in the investigation of biologically active compounds derived from marine organisms of the Far Eastern and tropical seas using advanced experimental models of human pathologies in laboratory animals. She works as a research assistant in the Laboratory of Molecular Pharmacology and Biomedicine at the Pacific Institute of Bioorganic Chemistry, contributing extensively to fundamental and applied biomedicine. Her scientific portfolio includes 40 publications indexed in Web of Science and Scopus, supported by 199 citations across 162 documents and an h-index of 8, reflecting her strong research impact. She has completed seven research projects and is an inventor or co-inventor on seven patents focused on bioactive marine compounds and their therapeutic potential. Her research areas span biology, biochemistry, biomedicine, natural biologically active substances, and preclinical trials, with collaborative work involving Far Eastern Federal University in Vladivostok. Dr. Klimovich has contributed significantly to the characterization of marine peptides and metabolites, including the sea anemone peptide HCRG21, which exhibits analgesic, anti-inflammatory, and anxiolytic activities and demonstrates therapeutic potential for allergic dermatitis and psoriasis. She has also studied the peptide HCIQ2c1 with anti-inflammatory and neuroprotective properties, and the sea anemone peptides Hcr 1b-2, Hcr 1b-4, and AnmTX Sco 9a-1, which show strong anxiolytic, anti-inflammatory, and analgesic effects. Her work further includes discovering the antidiabetic and antiglycemic activities of the peptide Mgf, evaluating antimicrobial and antitumor effects of phenylphascaplysine alkaloid derivatives, and identifying the ability of triterpene glycosides from sea cucumbers—Cucumarioside A0-1, Djakonovioside A—and the peptide Hct-S3 to inhibit tumor metastasis. Additionally, she contributed to demonstrating that asterripeptides A–C from marine fungi possess therapeutic activity in treating infected wounds. Her research advances marine-derived therapeutic discoveries with high relevance to pharmacology, biotechnology, and translational biomedicine.

Profiles: Scopus | Orcid

Featured Publications

Klimovich, A., Kvetkina, A., Deryavko, Y., Priymenko, N., Popkova, D., Bystritskaya, E., Isaeva, M., Gladkikh, I., Sintsova, O., & Leychenko, E. (2025). TRPV1 blocker, peptide HCRG21 from sea anemone Heteractis magnifica, exhibits effectiveness in psoriasis and dermatitis in in vivo models. International Journal of Molecular Sciences, 26(21), 10644. https://doi.org/10.3390/ijms262110644

Klimovich, A. A., Chingizova, E. A., Pislyagin, E. A., Kotelnikov, V. N., & Shperling, I. A. (2025). Eksperimental’no-funktsional’naya otsenka ranozazhivlyayushchey aktivnosti gidrogelya na osnove karboksimetiltsellyulozy s biologicheski aktivnymi veshchestvami iz gidrobiontov Tikhogo okeana pri termicheskom ozhoge [Experimental and functional evaluation of the wound-healing activity of a carboxymethylcellulose-based hydrogel with bioactive substances from Pacific Ocean hydrobionts in a thermal burn model]. Clinical and Fundamental Medicine, 2, 5–12. https://doi.org/10.24866/3033-5485/2025-2/5-12

Zhidkov, M. E., Smirnova, P. A., Grammatikova, N. E., Isakova, E. B., Shchekotikhin, A. E., Styshova, O. N., Klimovich, A. A., & Popov, A. M. (2025). Comparative evaluation of the antibacterial and antitumor activities of marine alkaloid 3,10-dibromofascaplysin. Marine Drugs, 23(2), 68. https://doi.org/10.3390/md23020068

Klimovich, A. A., Kvetkina, A. N., Deryavko, Y. V., Priymenko, N. A., & Leychenko, E. V. (2024). Peptide TRPV1 channel blocker, HCRG21, effectively suppresses inflammation in a calcipotriol-induced allergic dermatitis model. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18, (Issue no. pending). https://doi.org/10.1134/S1990750824601127

Pavlenko, A. P., Klimovich, A. A., Yurchenko, E. A., Kvetkina, A. N., & Leychenko, E. V. (2024). Sea anemone Heteractis magnifica toxin Hct-S3 suppresses the migration of solid Ehrlich adenocarcinoma cells inoculated into BALB/C mice. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18, (Issue no. pending). https://doi.org/10.1134/S1990750824601206

Klimovich, A. A., Styshova, O. N., Popov, A. M., Moskvina, T. V., Tsybulsky, A. V., Derunov, D. A., & Stonik, V. A. (2020). Experimental study of therapeutic efficacy of the topical preparation “Kourochitin” in skin allergy. Letters in Drug Design & Discovery, 17(10), 1234–1241.